IN2015DN01230A - Pyrrolopyrazoles as n type calcium channel blockers - Google Patents

Pyrrolopyrazoles as n type calcium channel blockers

Info

Publication number
IN2015DN01230A
IN2015DN01230A IN1230/DELNP/2015A IN1230DEN2015A IN2015DN01230A IN 2015DN01230 A IN2015DN01230 A IN 2015DN01230A IN 1230DEN2015 A IN1230DEN2015 A IN 1230DEN2015A IN 2015DN01230 A IN2015DN01230 A IN 2015DN01230A
Authority
IN
India
Prior art keywords
pyrrolopyrazoles
calcium channel
channel blockers
type calcium
compounds
Prior art date
Application number
IN1230/DELNP/2015A
Other languages
English (en)
Inventor
Michael P Winters
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49170857&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2015DN01230(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IN2015DN01230A publication Critical patent/IN2015DN01230A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN1230/DELNP/2015A 2012-08-16 2015-02-16 Pyrrolopyrazoles as n type calcium channel blockers IN2015DN01230A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261683780P 2012-08-16 2012-08-16
PCT/US2013/055275 WO2014028805A1 (fr) 2012-08-16 2013-08-16 Pyrrolopyrazoles comme bloqueurs de canal calcique de type n

Publications (1)

Publication Number Publication Date
IN2015DN01230A true IN2015DN01230A (en) 2015-06-26

Family

ID=49170857

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1230/DELNP/2015A IN2015DN01230A (en) 2012-08-16 2015-02-16 Pyrrolopyrazoles as n type calcium channel blockers

Country Status (19)

Country Link
US (1) US8846949B2 (fr)
EP (1) EP2885304B8 (fr)
JP (1) JP6250674B2 (fr)
KR (1) KR20150042271A (fr)
CN (1) CN104936960B (fr)
AU (1) AU2013302473B2 (fr)
BR (1) BR112015003359A2 (fr)
CA (1) CA2882127A1 (fr)
CL (1) CL2015000359A1 (fr)
CR (1) CR20150070A (fr)
EA (1) EA201590379A1 (fr)
ES (1) ES2607839T3 (fr)
IL (1) IL237192A0 (fr)
IN (1) IN2015DN01230A (fr)
MX (1) MX2015002039A (fr)
PE (1) PE20151139A1 (fr)
PH (1) PH12015500310A1 (fr)
SG (1) SG11201501133WA (fr)
WO (1) WO2014028805A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9974775B2 (en) 2013-08-16 2018-05-22 Janssen Pharmaceutica Nv Substituted imidazoles as N-type calcium channel blockers

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2882038A1 (fr) 2012-08-16 2014-02-20 Janssen Pharmaceutica Nv Pyrazoles substitues comme bloqueurs de canal calcique de type n
US10562896B2 (en) 2017-05-31 2020-02-18 Chemocentryx, Inc. 6-5 fused rings as C5a inhibitors
WO2018222601A1 (fr) * 2017-05-31 2018-12-06 Chemocentryx, Inc. Cycles 5-5 fusionnés utilisés en tant qu'inhibiteurs de c5a
WO2019126424A1 (fr) 2017-12-22 2019-06-27 Chemocentryx, Inc. Composés cycliques condensés 6,5 à substitution diaryle, utilisés en tant qu'inhibiteurs du c5ar
MX2020006460A (es) * 2017-12-22 2020-11-06 Chemocentryx Inc Compuestos de anillo 5,5 fusionado sustituido con diarilo como inhibidores de c5ar.
BR112020019822A2 (pt) 2018-04-02 2021-03-16 Chemocentryx, Inc. Profármacos de antagonistas bicíclicos fundidos de c5ar
CN112300169B (zh) * 2019-07-26 2022-03-04 上海美迪西生物医药股份有限公司 吡咯并吡唑类衍生物、其制备方法及其在医药上的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1287174B1 (it) 1996-11-15 1998-08-04 Angelini Ricerche Spa Diaril-ciclometilenpirazoli farmacologicamente attivi,procedimento per prepararli e composizioni farmaceutiche che li contengono
US7589116B2 (en) * 2003-04-03 2009-09-15 Merck & Co. Inc. Biaryl substituted pyrazoles as sodium channel blockers
US7145012B2 (en) * 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
ES2319539T3 (es) * 2003-09-17 2009-05-08 Janssen Pharmaceutica Nv Compuestos heterociclicos condensados como moduladores del receptor de serotonina.
FR2864958B1 (fr) 2004-01-12 2006-02-24 Sanofi Synthelabo Derive de n-[(1,5-diphenyl-1h-pyrazol-3-yl)methyl] sulfonamide, leur preparation et leur application en therapeutique.
EP1723123A4 (fr) * 2004-03-08 2009-12-02 Wyeth Corp Modulateurs de canaux ioniques
US20070191448A1 (en) * 2004-03-08 2007-08-16 Robert Zelle Ion channel modulators

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9974775B2 (en) 2013-08-16 2018-05-22 Janssen Pharmaceutica Nv Substituted imidazoles as N-type calcium channel blockers

Also Published As

Publication number Publication date
US8846949B2 (en) 2014-09-30
MX2015002039A (es) 2016-01-22
WO2014028805A1 (fr) 2014-02-20
EP2885304A1 (fr) 2015-06-24
CL2015000359A1 (es) 2015-04-24
SG11201501133WA (en) 2015-04-29
CR20150070A (es) 2015-05-18
CA2882127A1 (fr) 2014-02-20
EP2885304B8 (fr) 2016-12-07
CN104936960A (zh) 2015-09-23
AU2013302473B2 (en) 2017-08-10
AU2013302473A1 (en) 2015-02-26
EA201590379A1 (ru) 2015-06-30
CN104936960B (zh) 2016-12-28
JP6250674B2 (ja) 2017-12-20
IL237192A0 (en) 2015-04-30
KR20150042271A (ko) 2015-04-20
US20140051688A1 (en) 2014-02-20
ES2607839T3 (es) 2017-04-04
JP2015524853A (ja) 2015-08-27
PE20151139A1 (es) 2015-08-07
PH12015500310A1 (en) 2015-04-20
BR112015003359A2 (pt) 2017-07-04
EP2885304B1 (fr) 2016-09-21

Similar Documents

Publication Publication Date Title
PH12015500316A1 (en) Substituted pyrazoles as n-type calcium channel blockers
IN2015DN01230A (en) Pyrrolopyrazoles as n type calcium channel blockers
GEP201706695B (en) Substituted 4-phenyl-pyridi-nes for the treatment of nk-1 receptor related diseases
IN2015DN00960A (fr)
IN2014DN09346A (fr)
PH12016501192A1 (en) Tetrahydropyridopyrazines modulators of gpr6
PH12014502624B1 (en) Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
MX2015007097A (es) Nuevas fenil-piridinas/pirazinas bi-anulares para el tratamiento de cancer.
PH12014500814A1 (en) New aryl-quinoline derivatives
PH12015500315A1 (en) Substituted pyrozales as n-type calcium channel blockers
MX2016001855A (es) Nuevos aza-oxo-indoles para el tratamiento y profilaxis de la infeccion por virus sincitial respiratorio.
IN2012DN03846A (fr)
EA201491581A1 (ru) Везикулярные композиции
PH12015500314B1 (en) Cyclopentylpyrazoles as n-type calcium channel blockers
MX2016002043A (es) Imidazoles sustituidos como bloqueadores de canales de calcio tipo n.
EA201591449A1 (ru) Способы получения противораковых композиций
MX2015007460A (es) Agentes para el tratamiento del dolor y usos de los mismos.
PH12015502703A1 (en) Pharmaceutical compositions
MX2016001858A (es) Aza-oxo-indoles novedosos para el tratamiento y profilaxis de la infeccion por el virus sincicial respiratorio.
MX2014002343A (es) Inhibidores de parp.